Menu
Annual · values202120202019201820172016
Operating Cash Flow-12.66 M USD-14.48 M USD-31.51 M USD-45.06 M USD-35.17 M USD-19.60 M USD
Depreciation & Amortization
Stock-Based Compensation
Capital Expenditures
Cash Flow from Investing
Cash Flow from Financing
Dividends Paid
Stock Buybacks
Free Cash Flow-13.33 M USD-16.02 M USD-32.32 M USD-45.23 M USD-35.76 M USD-18.34 M USD

Viveve Medical Inc. specializes in the design, development, manufacturing, and marketing of medical devices primarily focused on women's health. Its flagship product, the Viveve System, employs Cryogen-cooled Monopolar Radiofrequency technology for non-invasive treatments addressing vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. This innovative medical technology plays a significant role in enhancing women's well-being by offering low-risk, high-reward procedures. Viveve Medical Inc. operates across a global network, including the Americas, Europe, and Asia-Pacific regions, making it a notable player in the healthcare sector, particularly within the medical devices industry.